Oxler Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Buy
1,597
+2
+0.1% +$342 0.08% 78
2025
Q4
$269K Buy
1,595
+1
+0.1% +$162 0.08% 81
2025
Q3
$230K Buy
1,594
+1
+0.1% +$136 0.07% 84
2025
Q2
$201K Hold
1,593
0.06% 85
2025
Q1
$204K Buy
1,593
+2
+0.1% +$271 0.07% 84
2024
Q4
$210K Hold
1,591
0.07% 84
2024
Q3
$232K Buy
1,591
+3
+0.2% +$434 0.08% 81
2024
Q2
$218K Sell
1,588
-272
-15% -$36.3K 0.08% 80
2024
Q1
$255K Buy
1,860
+1
+0.1% +$137 0.1% 80
2023
Q4
$253K Sell
1,859
-3,004
-62% -$367K 0.21% 66
2023
Q3
$595K Sell
4,863
-6
-0.1% -$763 0.3% 63
2023
Q2
$618K Buy
4,869
+1
+0% +$130 0.29% 67
2023
Q1
$629K Buy
4,868
+2
+0% +$262 0.31% 64
2022
Q4
$639K Sell
4,866
-247
-5% -$31.9K 0.34% 61
2022
Q3
$603K Buy
5,113
+255
+5% +$31.7K 0.34% 65
2022
Q2
$571K Buy
4,858
+2
+0% +$237 0.28% 75
2022
Q1
$632K Buy
4,856
+4
+0.1% +$521 0.29% 76
2021
Q4
$740K Buy
4,852
+1
+0% +$155 0.31% 79
2021
Q3
$784K Buy
4,851
+100
+2% +$16.8K 0.35% 77
2021
Q2
$777K Hold
4,751
0.34% 79
2021
Q1
$715K Hold
4,751
0.36% 74
2020
Q4
$719K Buy
+4,751
New +$679K 0.41% 57

Other funds holding IBB

Oxler Private Wealth's IBB Position: Q1 2026 in Review

Oxler Private Wealth increased its iShares Biotechnology ETF (IBB) stake by 0.13% in Q1 2026, buying an estimated $342 and bringing the position to 1,597 shares worth $270K. The position accounts for 0.08% of the portfolio, ranked #78.

Oxler Private Wealth first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. The position peaked at $784K in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Oxler Private Wealth held 1,597 shares of iShares Biotechnology ETF worth $270K as of Q1 2026.
  • Oxler Private Wealth bought 2 iShares Biotechnology ETF shares in Q1 2026, an estimated $342.
  • iShares Biotechnology ETF made up 0.08% of Oxler Private Wealth's portfolio in Q1 2026, its #78 holding.
  • Oxler Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • Oxler Private Wealth's iShares Biotechnology ETF position peaked at $784K in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Oxler Private Wealth's 13F filing for Q1 2026, filed 28 Apr 2026.